Table 2.
Patterns of Surveillance Drug Resistance Mutations in 26 Treatment-Naive Newly Diagnosed Patients from Croatia Infected with Genotype B of HIV-1 (2006–2008)
| Surveillance drug resistance mutations (SDRM) | Number of patients (n=26) |
|---|---|
| NRTI-associated SDRM | |
| T215S | 13 |
| F77L or M184V or T215C or T215D | 1 patient per each mutation |
| M41L+L210W+T215D | 2 |
| T215S+K219R | 1 |
| T215S+L210W | 2 |
| D67G+K219E | 1 |
| NNRTI-associated SDRM | |
| Y181DHNI | 1 |
| K101E | 1 |
| NRTI+NNRTI-associated SDRM | |
| T215S+K103N | 1 |
NRTI, nucleoside reverse transcriptase inhibitors; NNRTI, nonnucleoside reverse transcriptase inhibitors.